Page last updated: 2024-08-16

ribavirin and Liver Steatosis

ribavirin has been researched along with Liver Steatosis in 68 studies

Research

Studies (68)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	33 (48.53)	29.6817
2010's	35 (51.47)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Avram, L; Craciun, R; Crisan, D; Crisan, N; Epure, F; Grigorescu, M; Grigorescu, MD; Leach, N; Lupsor, M; Radu, C; Suciu, A	1
Crisan, D; Grigorescu, M; Grigorescu, MD; Radu, C; Suciu, A	1
Kanda, T; Moriyama, M	1
Arai, M; Chiba, T; Imazeki, F; Kanda, T; Mikata, R; Nakamoto, S; Nakamura, M; Shirasawa, H; Tawada, A; Wu, S; Yasui, S; Yokosuka, O	1
Chang, KC; Chen, CH; Hu, TH; Hung, CH; Kuo, FY; Lin, JT; Lin, MT; Lu, SN; Tsai, MC; Tseng, PL; Wang, JH; Wu, CK; Yen, YH	1
Akuta, N; Arase, Y; Fujiyama, S; Hosaka, T; Ikeda, K; Kawamura, Y; Kobayashi, M; Kominami, Y; Kumada, H; Ohya, K; Saitoh, S; Sezaki, H; Suzuki, F; Suzuki, Y	1
Izumi, T; Kawagishi, N; Kimura, M; Kudo, Y; Maehara, O; Miyoshi, H; Morikawa, K; Nakai, M; Nakamura, A; Natsuizaka, M; Nishida, M; Ogawa, K; Ohara, M; Sakamoto, N; Sho, T; Suda, G; Suzuki, K; Umemura, M	1
Berger, F; Boesecke, C; Buendgens, L; Christensen, S; Hüppe, D; Ingiliz, P; Lutz, T; Mauss, S; Schewe, K; Simon, KG; Tacke, F	1
Cooper, CL; Crawley, A; Doyle, MA; Galanakis, C; Mulvihill, E	1
Hisanaga, Y; Kanamori, A; Kiriyama, S; Kitabatake, S; Kumada, T; Murakami, Y; Tada, T; Tanikawa, M; Toyoda, H	1
Beinhardt, S; Ferenci, P; Hofer, H; Rutter, K; Scherzer, TM; Stättermayer, AF; Steindl-Munda, P; Strasser, M; Trauner, M; Wrba, F	1
Aziz, S; Mirza, T; Sohail, S	1
Callanan, M; Fugier, E; Hoang, XS; Jouvin-Marche, E; Leroy, V; Macek Jílková, Z; Marche, H; Marche, PN; Marlu, A; Sturm, N; Thelu, MA; Van Campenhout, N; Zarski, JP	1
Barrero Alor, F; Casado Monge, PG; Jiménez Macías, FM; Pujol de la Llave, E; Ramos Lora, M; Ruíz-Frutos, C	1
Chen, DS; Chen, PJ; Chung, CS; Kao, JH; Liang, CC; Lin, CK; Liu, CH; Liu, CJ; Su, TH; Yang, HC	1
Efinger, M; Herrmann, E; Lange, CM; von Wagner, M; Welsch, C; Welzel, TM; Zeuzem, S	1
Anand, B; Barange, K; Diago, M; Govindarajan, S; Hooper, G; Lin, A; Morgan, T; Rodriguez-Torres, M; Shiffman, M; Suter, F	1
Fehér, J; Hagymási, K	1
Barreiro, P; Soriano, V; Tuma, P; Vispo, E	1
Bonkovsky, HL; Chung, RT; Di Bisceglie, AM; Everhart, JE; Everson, GT; Ghany, MG; Greenson, JK; Hoefs, JC; Kim, HY; Lee, WM; Lindsay, KL; Lok, AS; Morishima, C; Sterling, RK	1
Fujita, N; Hara, N; Iwasa, M; Kaito, M; Kobayashi, Y; Kojima, Y; Miyachi, H; Takei, Y; Takeo, M; Tanaka, H	1
Dinya, E; Schaff, Z; Tulassay, Z; Werling, K	1
Ansaldi, F; Borro, P; Gentile, R; Icardi, G; Ravetti, G; Sumberaz, A; Testino, G	1
Banasch, M; Ellrichmann, M; Meier, JJ; Schmidt, WE; Schrader, H; Vollmer, K	1
Cross, TJ; Harrison, PM; Hughes, S; Nolan, J; Quaglia, A	1
Abdurakhmanov, D; Bakulin, I; Cheinquer, H; Geyvandova, N; Harrison, SA; McKenna, M; Morozov, V; Rabbia, M; Reddy, KR; Rodriguez-Torres, M; Shiffman, ML; Silva, GF; Stanciu, C; Thommes, JA	1
Abdo, AA; Ahmed, LR; Al-hamoudi, W; Al-Husseini, H; Al-Otaibi, MM; Albenmousa, A; Ali, SM; AlQaraawi, AM; AlSheikh, A; Alswat, KA; Hersi, A; Sanai, FM; Syed, M	1
Albrecht, J; Berg, T; Boparai, N; Brass, C; Bruix, J; Burroughs, M; Carrilho, F; Colombo, M; Craxi, A; Diago, M; Flamm, S; Gonçales, F; Griffel, L; Heathcote, EJ; McGarrity, T; Moreno-Otero, R; Munteanu, M; Poynard, T; Schiff, E; Schmidt, W; Silva, M; Terg, R	1
Borro, P; Testino, G	1
Sanyal, AJ	1
Jahan, S; Khaliq, S; Pervaiz, A	1
Duarte-Rojo, A; Feld, JJ; Heathcote, EJ	1
Abdurakhmanov, DT; Baĭzhanova, ZhZh; Ignatova, TM; Nekrasova, TP	1
Cabibi, D; Cammà, C; Craxì, A; Di Marco, V; Di Stefano, R; Marchesini, G; Petta, S	1
Amanzada, A; Blaschke, M; Goralczyk, A; Mihm, S; Moriconi, F; Ramadori, G; Schaefer, IM; van Thiel, D	1
Bibert, S; Bochud, PY; Cerny, A; Dollenmaier, G; Dufour, JF; Gerlach, TJ; Heim, MH; Kutalik, Z; Lange, CM; Malinverni, R; Moradpour, D; Morikawa, K; Müllhaupt, B; Negro, F	1
Ando, K; Fujinami, A; Fukuda, K; Hasegawa, Y; Hayashi, Y; Hotta, H; Imoto, S; Kim, KI; Kim, SR; Komaki, T; Kudo, M; Maekawa, Y; Nagata, Y; Nakajima, T; Ohta, M; Ohtani, A; Otono, Y; Saito, J; Sugimoto, K	1
Abe, H; Arihiro, K; Chayama, K; Hayes, CN; Hiraga, N; Hyogo, H; Imamura, M; Kimura, Y; Kohno, T; Miki, D; Ochi, H; Ohnishi, M; Takahashi, S; Tanaka, S; Tsuge, M; Zhang, Y	1
Balistreri, W; Barton, BA; Duggan, C; Gonzalez-Peralta, RP; Haber, B; Jonas, MM; Lobritto, S; Mitchell, PD; Mohan, P; Molleston, JP; Murray, KF; Narkewicz, MR; Rosenthal, P; Schwarz, KB; Shepherd, JA	1
Adinolfi, LE; Guerrera, B; Restivo, L; Ruggiero, L; Zampino, R	1
Bibert, S; Bochud, PY; Guedj, H; Guedj, J; Lagging, M; Negro, F; Neumann, AU; Westin, J	1
Cabibi, D; Cammà, C; Craxì, A; Di Marco, V; Handberg, A; Macaluso, FS; Marchesini, G; Petta, S	1
Albrecht, J; Goodman, Z; Manns, M; McHutchison, J; Poynard, T; Ratziu, V; Younossi, Z; Zeuzem, S	1
Dimitropoulou, D; Gogos, CA; Labropoulou-Karatza, C; Siagris, D; Theocharis, GJ; Thomopoulos, KC; Tsamantas, AC	1
Baldo, V; Bozzola, L; Carlotto, A; de Lalla, F; Fabris, P; Floreani, A; Giordani, MT; Negro, F; Rassu, M; Tramarin, A	1
Bacon, BR; Brunt, EM; Di Bisceglie, AM; Harrison, SA; Neuschwander-Tetri, BA; Oliver, DA; Qazi, RA	1
Fukunaga, K; Morita, M; Murao, S; Nishumi, T; Shibutani, Y; Tani, S; Uchikoga, O; Yagi, N	1
Bianchi, FB; Granito, A; Guidi, M; Lenzi, M; Muratori, L; Muratori, P; Pappas, G	1
Clouston, AD; Jonsson, JR; Lipka, GM; Powell, EE; Purdie, DM; Richardson, MM; Walsh, MJ	1
Akuta, N; Arase, Y; Hosaka, T; Ikeda, K; Kobayashi, M; Kumada, H; Saitoh, S; Sato, J; Sezaki, H; Someya, T; Suzuki, F; Suzuki, Y; Watahiki, S	1
Maier, KP	1
Gui Qiang, W; Jian Wu, Y; Shu Chen, L	1
Bejarano, PA; Casanova-Romero, PY; Martinez, EJ; Mindikoglu, AL; Regev, A; Schiff, ER; Tzakis, AG	1
Chen, CH; Eng, HL; Hu, TH; Hung, CH; Kuo, FY; Lee, CM; Lu, SN; Wang, JH	1
Antúnez, I; Aponte, N; Fernández-Carbia, A; Rodríguez-Perez, F; Toro, DH	1
Ansaldi, F; Gentile, R; Icardi, G; Ravetti, G; Sumberaz, A; Testino, G	1
Alessandri, A; Franco, V; Giannitrapani, L; Montalto, G; Rappa, F; Soresi, M; Tripi, S; Vuturo, O	1
Afdhal, NH; Conjeevaram, HS; Everhart, JE; Hoofnagle, JH; Kleiner, DE; Wahed, AS; Zacks, S	1
Dhillon, AP; Hellstrand, K; Lagging, M; Missale, G; Negro, F; Neumann, AU; Norkrans, G; Pawlotsky, JM; Romero, AI; Schalm, SW; Verheij-Hart, E; Westin, J; Zeuzem, S	1
Bini, EJ; Bräu, N; Cheung, RC; Currie, SL; Ho, SB; Hu, KQ; Jeffers, L; McCracken, JD; Morgan, T; Schmidt, WN; Shen, H; Wright, TL	1
Bonkovsky, HL; Chung, RT; Di Bisceglie, AM; Everhart, JE; Everson, GT; Ghany, MG; Greenson, JK; Lee, WM; Lindsay, KL; Lok, AS; Morgan, TR; Morishima, C; Padmanabhan, L; Shiffman, ML	1
Almasio, PL; Amato, M; Craxí, A; De Lisi, S; Di Marco, V; Ferraro, D; Giordano, C; Lo Iacono, O; Mineo, C; Petta, S; Rodolico, V; Venezia, G	1
Aida, K; Kurihara, H; Mikami, M; Nagashima, I; Shiga, J; Takikawa, H; Tanaka, A; Uegaki, S	1
Cammalleri, L; Colonna, V; Cristaldi, E; Gargante, MP; Malaguarnera, M; Romano, M; Vacante, M	1
Ackrill, A; Bernstein, D; Bodenheimer, H; Dienstag, JL; Govindarajan, S; Hadziyannis, SJ; Marcellin, P; Messinger, D; Rakela, J; Reddy, KR; Schmidt, G	1
Dalekos, GN; Germenis, A; Liaskos, C; Makaritsis, K; Rigopoulou, EI; Togousidis, E; Zografos, TA	1
Cacoub, P; Saadoun, D; Sène, D	1
Abdel-Hamid, M; Attala, M; El Hoseiny, M; El Makhzangy, H; Esmat, G; Fontanet, A; Gad, RR; Hasan, A; Males, S; Mohamed, MK; Shouman, S; Zalata, K	1

Reviews

5 review(s) available for ribavirin and Liver Steatosis

Article	Year
[Role of tenofovir in HIV and hepatitis C virus coinfection]. Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 8 Topics: Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; Chemical and Drug Induced Liver Injury; Disease Progression; Drug Hypersensitivity; Drug Interactions; Drug Therapy, Combination; Fatty Liver; Glucose Metabolism Disorders; Hepatitis C, Chronic; HIV Infections; Humans; Interferons; Liver; Liver Cirrhosis; Organophosphonates; Reverse Transcriptase Inhibitors; Ribavirin; Tenofovir	2008
Sequence variability of HCV Core region: important predictors of HCV induced pathogenesis and viral production. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2011, Volume: 11, Issue:3 Topics: Carcinoma, Hepatocellular; Cell Cycle; Drug Therapy, Combination; Fatty Liver; Genetic Variation; Hepacivirus; Hepatitis C Antigens; Hepatitis C, Chronic; Humans; Insulin Resistance; Interferons; Liver Neoplasms; Ribavirin; Viral Core Proteins; Virus Replication	2011
'Easy to treat' genotypes were not created equal: can rapid virological response (RVR) level the playing field? Journal of hepatology, 2011, Volume: 55, Issue:2 Topics: Antiviral Agents; Clinical Trials as Topic; Drug Resistance, Viral; Fatty Liver; Genotype; Hepacivirus; Hepatitis C, Chronic; Host-Pathogen Interactions; Humans; Insulin Resistance; Interferon Type I; Ribavirin; RNA, Viral; Treatment Outcome	2011
[Drug therapy in chronic liver disease]. Praxis, 2005, Nov-30, Volume: 94, Issue:48 Topics: Adenine; Administration, Oral; Anti-HIV Agents; Antiviral Agents; Azathioprine; Cholangitis, Sclerosing; Chronic Disease; Drug Therapy, Combination; Fatty Liver; Hemochromatosis; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatitis, Autoimmune; Hepatolenticular Degeneration; Humans; Immunosuppression Therapy; Interferons; Lamivudine; Liver Cirrhosis, Biliary; Liver Diseases; Organophosphonates; Prednisolone; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Ribavirin; Time Factors	2005
[Cryoglobulinemia]. La Revue de medecine interne, 2008, Volume: 29, Issue:3 Topics: Alcohol Drinking; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antiviral Agents; Cryoglobulinemia; Drug Therapy, Combination; Fatty Liver; Female; Hepatitis C; Humans; Immunologic Factors; Interferon-alpha; Liver Cirrhosis; Male; Recurrence; Ribavirin; Rituximab; Sex Factors; Vasculitis	2008

Trials

14 trial(s) available for ribavirin and Liver Steatosis

Article	Year
Hepatitis C Direct Acting Antivirals and Ribavirin Modify Lipid but not Glucose Parameters. Cells, 2019, 03-15, Volume: 8, Issue:3 Topics: Antiviral Agents; Apolipoproteins; Fatty Liver; Female; Glucose; Hepacivirus; Hepatitis C, Chronic; Homeostasis; Humans; Insulin Resistance; Lipids; Liver; Male; Middle Aged; Ribavirin; Treatment Outcome	2019
Evolution of hepatic steatosis in patients with advanced hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial. Hepatology (Baltimore, Md.), 2009, Volume: 49, Issue:6 Topics: Antiviral Agents; Disease Progression; Fatty Liver; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Time Factors	2009
Effect of liver steatosis on therapeutic response in chronic hepatitis C virus genotype 1 infected patients in hungary. Pathology oncology research : POR, 2010, Volume: 16, Issue:2 Topics: Antiviral Agents; Fatty Liver; Hepacivirus; Hepatitis C, Chronic; Humans; Hungary; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome	2010
Pegylated interferon alfa-2a and ribavirin treatment for recurrent hepatitis C: role of steatosis and body mass index. Panminerva medica, 2009, Volume: 51, Issue:2 Topics: Adult; Antiviral Agents; Biopsy; Body Mass Index; Drug Therapy, Combination; Fatty Liver; Female; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Recurrence; Ribavirin; Severity of Illness Index; Time Factors; Treatment Outcome; Viral Load	2009
Induction pegylated interferon alfa-2a and high dose ribavirin do not increase SVR in heavy patients with HCV genotype 1 and high viral loads. Gastroenterology, 2010, Volume: 139, Issue:6 Topics: Adult; Antiviral Agents; Body Weight; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fatty Liver; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Obesity; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Viral Load	2010
FibroTest is an independent predictor of virologic response in chronic hepatitis C patients retreated with pegylated interferon alfa-2b and ribavirin in the EPIC³ program. Journal of hepatology, 2011, Volume: 54, Issue:2 Topics: Adult; Alanine Transaminase; Biopsy; Drug Therapy, Combination; Fatty Liver; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Polyethylene Glycols; Prognosis; Prospective Studies; Recombinant Proteins; Ribavirin	2011
Pegylated interferon for chronic hepatitis C in children affects growth and body composition: results from the pediatric study of hepatitis C (PEDS-C) trial. Hepatology (Baltimore, Md.), 2012, Volume: 56, Issue:2 Topics: Adolescent; Antiviral Agents; Body Composition; Body Height; Body Mass Index; Body Weight; Child; Child, Preschool; Cohort Studies; Drug Therapy, Combination; Eating; Fatty Liver; Female; Growth Disorders; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Cirrhosis; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin	2012
Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C. Hepatology (Baltimore, Md.), 2003, Volume: 38, Issue:1 Topics: Adult; Antiviral Agents; Cholesterol; Drug Therapy, Combination; Fatty Liver; Female; Follow-Up Studies; Genotype; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Prevalence; Recombinant Proteins; Ribavirin	2003
Effects of fatty liver and related factors on the efficacy of combination antiviral therapy in patients with chronic hepatitis C. Liver international : official journal of the International Association for the Study of the Liver, 2006, Volume: 26, Issue:2 Topics: Adult; Antiviral Agents; China; Drug Therapy, Combination; Fatty Liver; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Injections, Subcutaneous; Insulin; Insulin Resistance; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Ultrasonography	2006
Impact of steatosis on long-term histological outcome in chronic hepatitis C after antiviral therapy. Antiviral therapy, 2006, Volume: 11, Issue:4 Topics: Adult; Aged; Antiviral Agents; Biopsy; Disease Progression; Fatty Liver; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver; Male; Middle Aged; Recombinant Proteins; Ribavirin; RNA, Viral	2006
Impact of hepatic steatosis on viral kinetics and treatment outcome during antiviral treatment of chronic HCV infection. Journal of viral hepatitis, 2007, Volume: 14, Issue:1 Topics: Adult; Antiviral Agents; Biopsy; Fatty Liver; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Kaplan-Meier Estimate; Kinetics; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome	2007
Clinical implications of hepatic steatosis in patients with chronic hepatitis C: a multicenter study of U.S. veterans. Digestive diseases and sciences, 2007, Volume: 52, Issue:2 Topics: Adult; Aged; Antiviral Agents; Body Mass Index; Fatty Liver; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Hospitals, Veterans; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Obesity; Prevalence; Prospective Studies; Recombinant Proteins; Ribavirin; Risk Factors; Severity of Illness Index; Treatment Outcome; United States	2007
Hepatic steatosis in hepatitis C: comparison of diabetic and nondiabetic patients in the hepatitis C antiviral long-term treatment against cirrhosis trial. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2007, Volume: 5, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Diabetes Mellitus; Disease Progression; Fatty Liver; Female; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Polyethylene Glycols; Prevalence; Prospective Studies; Recombinant Proteins; Ribavirin; Risk Factors	2007
L-carnitine treatment reduces steatosis in patients with chronic hepatitis C treated with alpha-interferon and ribavirin. Digestive diseases and sciences, 2008, Volume: 53, Issue:4 Topics: Adult; Antiviral Agents; Carnitine; Drug Therapy, Combination; Fatty Liver; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Function Tests; Male; Middle Aged; Ribavirin; Vitamin B Complex	2008

Other Studies

49 other study(ies) available for ribavirin and Liver Steatosis

Article	Year
Association between PNPLA3[G]/I148M variant, steatosis and fibrosis stage in hepatitis C virus - genetic matters. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2019, Volume: 70, Issue:4 Topics: Antiviral Agents; Disease Progression; Fatty Liver; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lipase; Liver; Liver Cirrhosis; Male; Membrane Proteins; Middle Aged; Polyethylene Glycols; Polymorphism, Single Nucleotide; Recombinant Proteins; Ribavirin; RNA, Viral	2019
Interferon-γ-inducible protein-10 in chronic hepatitis C: Correlations with insulin resistance, histological features & sustained virological response. The Indian journal of medical research, 2017, Volume: 145, Issue:4 Topics: Adult; Aged; Antiviral Agents; Biopsy; Chemokine CXCL10; Enzyme-Linked Immunosorbent Assay; Fatty Liver; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Insulin Resistance; Interferon-gamma; Liver; Male; Middle Aged; Ribavirin; Treatment Outcome; Viral Load	2017
Direct-acting antiviral agents against hepatitis C virus and lipid metabolism. World journal of gastroenterology, 2017, Aug-21, Volume: 23, Issue:31 Topics: Antiviral Agents; Cholesterol; Drug Therapy, Combination; Fatty Liver; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Lipid Metabolism; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Triglycerides	2017
Association of International journal of medical sciences, 2017, Volume: 14, Issue:11 Topics: Adult; Aged; Antiviral Agents; Fatty Liver; Female; Genotype; Hepatitis C, Chronic; Humans; Interferon-alpha; Interferons; Interleukins; Male; Middle Aged; Retrospective Studies; Ribavirin	2017
The association between steatosis and diabetes with hepatocellular carcinoma in non-genotype 3 chronic hepatitis C patients. Liver international : official journal of the International Association for the Study of the Liver, 2018, Volume: 38, Issue:6 Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Diabetes Complications; Diabetes Mellitus; Fatty Liver; Female; Genotype; Hepatitis C, Chronic; Humans; Interferons; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Retrospective Studies; Ribavirin; Risk Factors; Sustained Virologic Response; Taiwan	2018
Predictors of treatment efficacy and liver stiffness changes following therapy with Sofosbuvir plus Ribavirin in patients infected with HCV genotype 2. Journal of medical virology, 2018, Volume: 90, Issue:5 Topics: Adult; Aged; Aged, 80 and over; alpha-Fetoproteins; Antiviral Agents; Drug Therapy, Combination; Fatty Liver; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Liver; Liver Cirrhosis; Male; Middle Aged; Prognosis; Retrospective Studies; Ribavirin; Sofosbuvir; Sustained Virologic Response; Treatment Outcome; Young Adult	2018
Liver steatosis and dyslipidemia after HCV eradication by direct acting antiviral agents are synergistic risks of atherosclerosis. PloS one, 2018, Volume: 13, Issue:12 Topics: Adult; Aged; Antiviral Agents; Atherosclerosis; Cholesterol, LDL; Dyslipidemias; Fatty Liver; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Lipid Metabolism; Liver; Male; Middle Aged; Ribavirin; Risk Factors; Sustained Virologic Response	2018
Risk factors for remaining liver injury in patients with virological elimination of chronic hepatitis C. Zeitschrift fur Gastroenterologie, 2019, Volume: 57, Issue:2 Topics: Alanine Transaminase; Antiviral Agents; Fatty Liver; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Male; Middle Aged; Obesity; Prospective Studies; Ribavirin; Risk Factors; Sex Factors	2019
Association between hepatic steatosis and hepatic expression of genes involved in innate immunity in patients with chronic hepatitis C. Cytokine, 2013, Volume: 63, Issue:2 Topics: Adaptor Proteins, Signal Transducing; Antiviral Agents; DEAD Box Protein 58; DEAD-box RNA Helicases; Drug Resistance, Viral; Drug Therapy, Combination; Fatty Liver; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Immunity, Innate; Interferon alpha-2; Interferon-alpha; Liver; Male; Middle Aged; Polyethylene Glycols; Receptors, Immunologic; Recombinant Proteins; Ribavirin; RNA, Messenger; Ubiquitin-Protein Ligases	2013
Role of FDFT1 polymorphism for fibrosis progression in patients with chronic hepatitis C. Liver international : official journal of the International Association for the Study of the Liver, 2014, Volume: 34, Issue:3 Topics: Adult; Alleles; Antiviral Agents; Disease Progression; Farnesyl-Diphosphate Farnesyltransferase; Fatty Liver; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Cirrhosis; Logistic Models; Male; Middle Aged; Polyethylene Glycols; Polymorphism, Single Nucleotide; Recombinant Proteins; Ribavirin; Risk Factors; RNA, Viral	2014
Ultrasound based evaluation of hepatic steatosis and fibrosis in hepatitis C non-responders. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2013, Volume: 23, Issue:8 Topics: Adult; Aged; Biopsy; Cross-Sectional Studies; Fatty Liver; Female; Fibrosis; Hepatitis C, Chronic; Humans; Interferons; Liver Cirrhosis; Male; Middle Aged; Predictive Value of Tests; Ribavirin; Sensitivity and Specificity; Treatment Failure; Ultrasonography; Young Adult	2013
Lymphocytes degranulation in liver in hepatitis C virus carriers is associated with IFNL4 polymorphisms and ALT levels. The Journal of infectious diseases, 2014, Jun-15, Volume: 209, Issue:12 Topics: Adult; Alanine Transaminase; Antiviral Agents; Cell Degranulation; Fatty Liver; Female; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Interleukins; Liver; Lymphocytes; Lysosomal-Associated Membrane Protein 1; Male; Middle Aged; Multivariate Analysis; Natural Killer T-Cells; Non-alcoholic Fatty Liver Disease; Polymorphism, Genetic; Ribavirin; RNA, Viral; Viral Load	2014
[Lipid kinetics during dual antiviral therapy in patients with chronic hepatitis C]. Medicina clinica, 2015, Jun-22, Volume: 144, Issue:12 Topics: Adult; Antiviral Agents; Chemokine CXCL10; Cholesterol; Drug Therapy, Combination; False Positive Reactions; Fatty Liver; Female; Follow-Up Studies; Genotype; Hepatitis C, Chronic; Humans; Hypertriglyceridemia; Interferon-alpha; Interferons; Interleukins; Lipids; Lipoproteins; Liver Cirrhosis; Male; Middle Aged; Polyethylene Glycols; Polymorphism, Single Nucleotide; Prospective Studies; Recombinant Proteins; Ribavirin; ROC Curve; Sensitivity and Specificity; Severity of Illness Index; Treatment Outcome; Viral Load; Viremia	2015
Advanced hepatic fibrosis and steatosis are associated with persistent alanine aminotransferase elevation in chronic hepatitis C patients negative for hepatitis C virus RNA during pegylated interferon plus ribavirin therapy. The Journal of infectious diseases, 2015, May-01, Volume: 211, Issue:9 Topics: Adult; Aged; Alanine Transaminase; Antiviral Agents; Drug Therapy, Combination; Fatty Liver; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral	2015
Ongoing liver inflammation in patients with chronic hepatitis C and sustained virological response. PloS one, 2017, Volume: 12, Issue:2 Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Fatty Liver; Hepacivirus; Hepatitis; Hepatitis C, Chronic; Humans; Interferon-alpha; Logistic Models; Middle Aged; Multivariate Analysis; Outcome Assessment, Health Care; Polyethylene Glycols; Prospective Studies; Retrospective Studies; Ribavirin; Risk Factors; Sustained Virologic Response; Time Factors; Transaminases	2017
Hepatic steatosis in patients with chronic hepatitis C virus genotype 2 or 3 does not affect viral response in patients treated with peginterferon alpha-2a (40KD) (PEGASYS) plus ribavirin (COPEGUS) for 16 or 24 weeks. Liver international : official journal of the International Association for the Study of the Liver, 2009, Volume: 29, Issue:2 Topics: Age Factors; Body Weight; Fatty Liver; Genotype; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Logistic Models; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Viral Load	2009
[Influence of weight reduction on the effectiveness of combined peginterferon and ribavirin treatment in chronic HCV hepatitis]. Orvosi hetilap, 2008, Nov-16, Volume: 149, Issue:46 Topics: Amantadine; Antioxidants; Antiviral Agents; Drug Therapy, Combination; Fatty Liver; Hepatitis C, Chronic; Humans; Insulin Resistance; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Obesity; Polyethylene Glycols; Protective Agents; Recombinant Proteins; Ribavirin; Silymarin; Treatment Outcome; Weight Loss	2008
Patients achieving clearance of HCV with interferon therapy recover from decreased retinol-binding protein 4 levels. Journal of viral hepatitis, 2009, Volume: 16, Issue:10 Topics: Aged; Antiviral Agents; Fatty Liver; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver; Liver Cirrhosis; Male; Middle Aged; Plasma; Polyethylene Glycols; Recombinant Proteins; Retinol-Binding Proteins, Plasma; Ribavirin; Severity of Illness Index; Viral Load	2009
Sustained virological response during exenatide treatment in a patient with hepatitis C and nonalcoholic steatohepatitis. The American journal of gastroenterology, 2009, Volume: 104, Issue:12 Topics: Antiviral Agents; Drug Therapy, Combination; Exenatide; Fatty Liver; Hepatitis C, Chronic; Humans; Hypoglycemic Agents; Interferon alpha-2; Interferon-alpha; Liver Function Tests; Male; Middle Aged; Peptides; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; Venoms; Viral Load	2009
Do steatosis and steatohepatitis impact on sustained virological response (SVR) rates in patients receiving pegylated interferon and ribavirin for chronic hepatitis C infection? Journal of medical virology, 2010, Volume: 82, Issue:6 Topics: Adult; Antiviral Agents; Biopsy; Fatty Liver; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Histocytochemistry; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome; Viral Load	2010
Prevalence and impact of hepatic steatosis on the response to antiviral therapy in Saudi patients with genotypes 1 and 4 chronic hepatitis C. Digestive diseases and sciences, 2011, Volume: 56, Issue:4 Topics: Adult; Antiviral Agents; Biopsy; Body Mass Index; Diabetes Mellitus; Fatty Liver; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Hyperlipidemias; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Prevalence; Recombinant Proteins; Retrospective Studies; Ribavirin; Saudi Arabia; Severity of Illness Index	2011
Hepatitis C recurrence: influence of serum cholesterol levels and liver steatosis on antiviral therapy. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:4 Topics: Antiviral Agents; Body Mass Index; Cholesterol; Fatty Liver; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Polyethylene Glycols; Recombinant Proteins; Recurrence; Ribavirin; Triglycerides; Viral Load	2011
Role of insulin resistance and hepatic steatosis in the progression of fibrosis and response to treatment in hepatitis C. Liver international : official journal of the International Association for the Study of the Liver, 2011, Volume: 31 Suppl 1 Topics: Antiviral Agents; Fatty Liver; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Insulin Resistance; Interferon alpha-2; Interferon-alpha; MicroRNAs; Polyethylene Glycols; Recombinant Proteins; Ribavirin	2011
[Metabolic syndrome in patients with chronic hepatitis C genotype 1]. Vestnik Rossiiskoi akademii meditsinskikh nauk, 2011, Issue:1 Topics: Adult; Antiviral Agents; Fatty Liver; Female; Genome, Viral; Hepacivirus; Hepatitis C, Chronic; Hepatocytes; Humans; Insulin Resistance; Interferon alpha-2; Interferon-alpha; Leptin; Liver Cirrhosis; Male; Metabolic Syndrome; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Severity of Illness Index; Treatment Outcome	2011
TyG index, HOMA score and viral load in patients with chronic hepatitis C due to genotype 1. Journal of viral hepatitis, 2011, Volume: 18, Issue:7 Topics: Adult; Aged; Antiviral Agents; Blood Glucose; Body Mass Index; Drug Therapy, Combination; Fatty Liver; Female; Hepacivirus; Hepatitis C, Chronic; Homeostasis; Humans; Insulin Resistance; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome; Triglycerides; Viral Load	2011
Ultra-rapid virological response, young age, low γ-GT/ALT-ratio, and absence of steatosis identify a subgroup of HCV Genotype 3 patients who achieve SVR with IFN-α(2a) monotherapy. Digestive diseases and sciences, 2011, Volume: 56, Issue:11 Topics: Adult; Age Factors; Alanine Transaminase; Antiviral Agents; Drug Therapy, Combination; Fatty Liver; Female; gamma-Glutamyltransferase; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver; Male; Middle Aged; Polymorphism, Single Nucleotide; Recombinant Proteins; Retrospective Studies; Ribavirin; Young Adult	2011
Serum ferritin levels are associated with a distinct phenotype of chronic hepatitis C poorly responding to pegylated interferon-alpha and ribavirin therapy. Hepatology (Baltimore, Md.), 2012, Volume: 55, Issue:4 Topics: Adolescent; Adult; Aged; Antiviral Agents; Biomarkers; Drug Therapy, Combination; Fatty Liver; Female; Ferritins; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Incidence; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Phenotype; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Factors; Treatment Outcome; Young Adult	2012
Correlation between insulin resistance and outcome of pegylated interferon and ribavirin therapy, hepatic steatosis, hepatic fibrosis in chronic hepatitis C-1b and high viral load. Digestion, 2011, Volume: 84 Suppl 1 Topics: Aged; Antiviral Agents; Body Mass Index; Drug Therapy, Combination; Fatty Liver; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Insulin Resistance; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome; Viral Load	2011
IL28B polymorphism is associated with fatty change in the liver of chronic hepatitis C patients. Journal of gastroenterology, 2012, Volume: 47, Issue:7 Topics: Adolescent; Adult; Aged; Antiviral Agents; Fatty Liver; Female; Genotype; Hepatitis C, Chronic; Humans; Interferons; Interleukins; Liver; Logistic Models; Male; Middle Aged; Polyethylene Glycols; Polymorphism, Single Nucleotide; Ribavirin; Young Adult	2012
Steatosis is the predictor of relapse in HCV genotype 3- but not 2-infected patients treated with 12 weeks of pegylated interferon-α-2a plus ribavirin and RVR. Journal of viral hepatitis, 2012, Volume: 19, Issue:5 Topics: Adult; Antiviral Agents; Fatty Liver; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Prognosis; Recombinant Proteins; Recurrence; Ribavirin; RNA, Viral; Treatment Outcome	2012
The impact of fibrosis and steatosis on early viral kinetics in HCV genotype 1-infected patients treated with Peg-IFN-alfa-2a and ribavirin. Journal of viral hepatitis, 2012, Volume: 19, Issue:7 Topics: Adult; Antiviral Agents; Fatty Liver; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver; Liver Cirrhosis; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome; Viral Load	2012
High sCD36 plasma level is associated with steatosis and its severity in patients with genotype 1 chronic hepatitis C. Journal of viral hepatitis, 2013, Volume: 20, Issue:3 Topics: Adult; Aged; Antiviral Agents; Biomarkers; Biopsy; CD36 Antigens; Enzyme-Linked Immunosorbent Assay; Fatty Liver; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Liver; Male; Middle Aged; Plasma; Ribavirin; Severity of Illness Index	2013
Liver steatosis is an independent risk factor for treatment failure in patients with chronic hepatitis C. European journal of gastroenterology & hepatology, 2005, Volume: 17, Issue:2 Topics: Adolescent; Adult; Age Factors; Aged; Antiviral Agents; Body Mass Index; Drug Therapy, Combination; Fatty Liver; Female; Genotype; Hepatitis C, Chronic; Humans; Interferons; Logistic Models; Male; Middle Aged; Retrospective Studies; Ribavirin; Risk Factors; Treatment Failure	2005
Impact of liver steatosis on virological response in [corrected] Italian patients with chronic hepatitis C treated with peg-interferon alpha-2b plus ribavarin. Alimentary pharmacology & therapeutics, 2005, May-01, Volume: 21, Issue:9 Topics: Adult; Antiviral Agents; Drug Evaluation; Drug Therapy, Combination; Fatty Liver; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Treatment Outcome	2005
Effect of significant histologic steatosis or steatohepatitis on response to antiviral therapy in patients with chronic hepatitis C. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2005, Volume: 3, Issue:6 Topics: Antiviral Agents; Biopsy; Fatty Liver; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Male; Middle Aged; Odds Ratio; Retrospective Studies; Ribavirin; RNA, Viral; Severity of Illness Index; Treatment Outcome; Virulence	2005
[Type 2 diabetes mellitus with histological finding of nonalcoholic steatohepatitis following combination therapy with interferon and ribavirin for chronic hepatitis C]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2005, Volume: 102, Issue:8 Topics: Adult; Antiviral Agents; Chemical and Drug Induced Liver Injury; Diabetes Mellitus, Type 2; Fatty Liver; Hepatitis C, Chronic; Humans; Interferons; Male; Ribavirin	2005
Hepatic steatosis in chronic hepatitis C: impact on response to anti-viral treatment with peg-interferon and ribavirin. Alimentary pharmacology & therapeutics, 2005, Nov-15, Volume: 22, Issue:10 Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Fatty Liver; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin	2005
Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1. Gut, 2006, Volume: 55, Issue:4 Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Fatty Liver; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Immunohistochemistry; Insulin Resistance; Interferon alpha-2; Interferon-alpha; Liver; Male; Middle Aged; Obesity; Phosphoenolpyruvate Carboxykinase (GTP); Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Signal Transduction; Suppressor of Cytokine Signaling 3 Protein; Suppressor of Cytokine Signaling Proteins; Treatment Outcome	2006
Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load. Journal of medical virology, 2006, Volume: 78, Issue:1 Topics: Adult; Aged; Amino Acid Substitution; Antiviral Agents; Case-Control Studies; Drug Therapy, Combination; Fatty Liver; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Interferons; Male; Middle Aged; Mutation, Missense; Ribavirin; Risk Factors; RNA, Viral; Treatment Outcome; Viral Load	2006
The impact of nonalcoholic fatty liver disease and the metabolic syndrome on progression of fibrosis in patients with recurrent HCV after liver transplantation. Transplantation proceedings, 2006, Volume: 38, Issue:5 Topics: Adult; Antiviral Agents; Biopsy; Cholesterol, HDL; Disease Progression; Fatty Liver; Female; Hepatitis C; Humans; Liver Cirrhosis; Living Donors; Male; Metabolic Syndrome; Middle Aged; Postoperative Complications; Recurrence; Retrospective Studies; Ribavirin; Triglycerides	2006
Steatosis as a predictive factor for treatment response in patients with chronic hepatitis C. Puerto Rico health sciences journal, 2004, Volume: 23, Issue:2 Suppl Topics: Adult; Aged; Antiviral Agents; Drug Therapy, Combination; Fatty Liver; Female; Hepatitis C, Chronic; Humans; Interferons; Male; Middle Aged; Prognosis; Retrospective Studies; Ribavirin; Risk Factors; Treatment Outcome	2004
Pegylated interferon (PEG-IFN) alfa-2b and ribavirin for recurrent hepatitis C (genotype 1) after liver transplantation: relationship with steatosis. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2006, Volume: 38, Issue:11 Topics: Adult; Antiviral Agents; Body Mass Index; Cholesterol; Drug Therapy, Combination; Fatty Liver; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Prospective Studies; Recombinant Proteins; Recurrence; Ribavirin; Triglycerides	2006
Impact of liver steatosis on the antiviral response in the hepatitis C virus-associated chronic hepatitis. Liver international : official journal of the International Association for the Study of the Liver, 2006, Volume: 26, Issue:9 Topics: Adult; Aging; Alanine Transaminase; Antiviral Agents; Aspartate Aminotransferases; Body Mass Index; Drug Therapy, Combination; Fatty Liver; Female; gamma-Glutamyltransferase; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Severity of Illness Index; Treatment Outcome	2006
Race, insulin resistance and hepatic steatosis in chronic hepatitis C. Hepatology (Baltimore, Md.), 2007, Volume: 45, Issue:1 Topics: Adult; Antiviral Agents; Black or African American; Drug Therapy, Combination; Fatty Liver; Female; Hepatitis C, Chronic; Humans; Insulin Resistance; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Multivariate Analysis; Polyethylene Glycols; Prevalence; Prospective Studies; Recombinant Proteins; Ribavirin; Severity of Illness Index; Signal Transduction; White People	2007
The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis C. Alimentary pharmacology & therapeutics, 2007, May-15, Volume: 25, Issue:10 Topics: Adipocytes; Adult; Antiviral Agents; Fatty Liver; Female; Hepatitis C, Chronic; Humans; Insulin Resistance; Interferon alpha-2; Interferon-alpha; Intra-Abdominal Fat; Liver Cirrhosis; Male; Middle Aged; Obesity; Recombinant Proteins; Ribavirin	2007
Hepatic steatosis as a possible risk factor for the development of hepatocellular carcinoma after eradication of hepatitis C virus with antiviral therapy in patients with chronic hepatitis C. World journal of gastroenterology, 2007, Oct-21, Volume: 13, Issue:39 Topics: Aged; Antiviral Agents; Carcinoma, Hepatocellular; Fatty Liver; Female; Follow-Up Studies; Hepacivirus; Hepatitis C; Humans; Interferons; Kaplan-Meier Estimate; Liver; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Ribavirin; Risk Factors; RNA, Viral	2007
Hepatic steatosis in chronic hepatitis C: baseline host and viral characteristics and influence on response to therapy with peginterferon alpha-2a plus ribavirin. Journal of viral hepatitis, 2008, Volume: 15, Issue:2 Topics: Antiviral Agents; Clinical Trials as Topic; Drug Combinations; Fatty Liver; Genotype; Hepacivirus; Hepatitis C, Chronic; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Randomized Controlled Trials as Topic; Recombinant Proteins; Retrospective Studies; Ribavirin	2008
Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C. The American journal of gastroenterology, 2008, Volume: 103, Issue:3 Topics: Adiponectin; Adult; Antiviral Agents; Biomarkers; Body Mass Index; Drug Therapy, Combination; Fatty Liver; Female; Genotype; Hepacivirus; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Ribavirin; RNA, Viral; Tumor Necrosis Factor-alpha	2008
Predictors of a sustained virological response in patients with genotype 4 chronic hepatitis C. Liver international : official journal of the International Association for the Study of the Liver, 2008, Volume: 28, Issue:8 Topics: Adult; alpha-Fetoproteins; Antiviral Agents; Fatty Liver; Female; Follow-Up Studies; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Logistic Models; Male; Medication Adherence; Middle Aged; Multivariate Analysis; Polyethylene Glycols; Randomized Controlled Trials as Topic; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome	2008